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Hypercalcaemia has been known to occur in association with granulomatous diseases. The aim of this study was to
ascertain the incidence of hypercalcaemia and determine the prevalence of symptoms associated with it in Greek
patients with newly-diagnosed tuberculosis (TB), before the initiation of anti-tuberculosis treatment. We
prospectively evaluated all patients with newly-diagnosed TB presenting, either as inpatients or as outpatients,
to our hospital, during a 3-year period. We evaluated 88 patients with TB (50 males and 38 females), aged between
23 and 89 years (mean age+SD: 46?4+19 years), and 65 age- and sex-matched controls with chronic obstructive
pulmonary disease (36 males and 29 females), aged between 28 and 88 years (mean age+SD: 47?2+18 years).
Among TB patients, 56 had pulmonary TB, 20 had pleural TB without evidence of pulmonary parenchyma
involvement, eight had pulmonary and pleural TB, and four had disseminated disease.
The mean (+SD) albumin–adjusted serum calcium concentration and the mean ionized calcium concentration
were significantly higher in the TB group (2?49+0?21mmol l71 and 1?27+0?02 mmol l71 respectively) than in the
control group (2?36+0?11 mmol l71 and 1?19+0?02mmol l71, P50?05). In the TB group no correlation between
type of disease and albumin-adjusted or ionized calcium concentration was seen. Hypercalcaemia was detected in
22 patients with TB (25%) but only three showed symptoms associated with it. We conclude that, although
hypercalcaemia is a common laboratory finding among Greek patients with TB before anti-TB chemotherapy, it is
usually asymtomatic.
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Many diseases involving granulomatous processes can
result in abnormalities of calcium metabolism. Sarcoidosis
is the most common granulomatous disease causing
hypercalcaemia. Tuberculosis (TB), disseminated coccidio-
mycosis and histoplasmosis have also been reported to be
associated with hypercalcaemia (1).
The incidence of hypercalcaemia in TB patients varies
widely between countries. The main reasons are the
differences in the vitamin D and calcium intake and the
different amount of sun exposure. Another important
reason is the various laboratory criteria for the definition
of hypercalcaemia. It is known that a component of totalReceived 16 October 2000 and accepted in revised form 1
December 2000.
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0954-6111/01/030187+04 $35?00/0serum calcium is complexed with either albumin (40%) or
globulins (8%); however, only the free or ionized calcium is
the physiologically relevant portion of this mineral ion (2).
If the serum calcium is reduced, as often occurs with the
anorexia and catabolic wasting that accompany TB, then
total serum calcium may be normal, although ionized
hypercalcaemia and its resultant symptoms are present. It
is, therefore, essential to correct the serum calcium for the
serum albumin concentration or, ideally, to measure serum
ionized calcium (3). Studies from India and the U.S.A that
did not use correction for patients with hypoalbuminaemia
indicated that 16–28% of TB patients may develop
hypercalcaemia (4,5). In contrast, studies using the albumin-
adjusted serum calcium concentration have reported higher
prevalence rates (6,7). As far as we know, the serum ionized
calcium concentration has not been used yet for the
recognition of hypercalcaemia in TB patients.
In Greece, a previous study on TB patients during the
treatment period showed that hypercalcaemia is common,# 2001 HARCOURT PUBLISHERS LTD
TABLE 1. Types of tuberculosis
Types Patients (n)
Pulmonary 56
Pulmonary and tuberculous pleurisy 8
Pleural without pulmonary involvement 20
Disseminated 4
Total 88
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study, which used both the albumin-adjusted and the
serum-ionized calcium concentration, was to ascertain the
incidence of hypercalcaemia and to determine the pre-
valence of symptoms associated with it in Greek patients
with newly-diagnosed TB, before anti-TB therapy.
Methods
The present study was conducted at the Ninth Department
of Pulmonary Medicine, in ‘Sotiria’ Chest Diseases
Hospital (Athens, Greece). Following a predefined proto-
col, between 1 March, 1997 and 31 March, 2000 we
prospectively studied 88 consecutive patients with newly-
diagnosed TB. Only patients with a proven bacteriologi-
cally and/or histologically diagnosis were included in the
study.
The diagnosis of TB was based on one or more of the
following criteria in the relevant tissue or specimen: (1)
positive smear of acid-fast bacilli, (2) positive culture for
Mycobacterium tuberculosis and (3) presence of necrotic
caseous granulomas in biopsy. Patients with known calcium
metabolism disorders, such as primary and metastatic
neoplastic disease, primary hyperparathyroidism, milk
alkali syndrome, adrenal insuciency, hyperthyroidism
and patients receiving steroids or vitamin D supplements
were excluded from the analysis. Moreover, the hypercal-
caemic patients had undergone thorough investigation to
exclude other causes of hypercalcaemia. Our control
subjects included 65 age- and sex-matched patients with
chronic obstructive pulmonary disease (COPD) hospita-
lized during the study period. Those with co-existing
disorders known to affect calcium metabolism were not
included.
In both study and control groups, venous blood was
drawn with minimal venostasis after overnight fasting for
the measurement of serum calcium, phosphorus, alkaline
phosphatase, BUN, total protein and albumin by a multi-
channel automated analyser. To allow for protein binding
of calcium, we assumed that 0?025mmol l71 of calcium is
bound per gram of albumin. Thus, the measured total
serum calcium concentration was corrected for serum
albumin levels by adding of subtracting 0?025mmol7l of
calcium for each 1 g dl7l of serum albumin short or in
excess of 4 g dl7l, respectively. Hypercalcaemia was defined
as an albumin-adjusted serum calcium level greater than
2?62mmol l7l. Furthermore, we measured ionized calcium
concentration in arterial blood sample collected into
heparinized (20–30 IUml7l ) glass capillary tubes. Ionized
calcium was measured simultaneously at 378C with a
semiautomatic ICA1TM analyser. Hypercalcaemia was
considered present if the ionized calcium concentration
was above the normal range of 1?13–1?32 mmol l7l.
Results are expressed as mean+1standard deviation (SD).
Significance of difference between groups was assessed by
an unpaired Student’s t-test for continuous variables and w
test for proportions. Correlation coecients between
variables were determined by simple regression analysis.
The Newman–Keuls multiple comparisons test was used todetermine whether the type of TB had any effect on serum
calcium concentration.
Results
During the study period TB was diagnosed and confirmed
in 88 patients aged 46?4+19 years. Fifty were men aged
45?8+18?3 years and 38 were women aged 46?9+19?3 years
(male:female ratio 1:3). Table 1 summarizes the distribution
of the types of TB and the number of patients with each
type. Our control subjects included 65 age- and sex-
matched patients with COPD (36 men aged 48?9+17?2
years and 29 women aged 46?4+17?9 years).
The mean serum albumin level among TB patients was
3?1+0?6 g dl71 ). Hypoalbuminaemia (serum albumin level
53?5 g dl71) was present in 44 patients (50%) at diagnosis,
before commencement of anti-TB chemotherapy. The mean
albumin-adjusted serum calcium concentration before
treatment was 2?49+0?21mmol l71 (range: 2?16–
3?69mmol l71). The mean ionized calcium concentration
in arterial blood was 1?27+0?02mmol l71 (range: 1?14–
1?41mmol l71). Pretreatment hypercalcaemia was present
in 22 patients (25%). In all cases of hypercalcaemia, both
albumin-adjusted and ionized calcium concentrations were
above the normal range. Age and sex had no effect on the
calcium levels.
The mean serum albumin level in the controls was
significantly higher than that of the TB patients
(3?9+0?5 g dl71, P50?01) while their albumin-adjusted
calcium concentration (2?36+0?11mmol l71) and ionized
calcium concentration (1?19+0?02mmol l71) were signifi-
cantly lower (P50?01 in both cases, Table 2). None of the
control patients had hypercalcaemia. The types of TB and
the serum calcium levels are also shown in Table 2. The
differences in the serum albumin-adjusted calcium concen-
tration among the various types of TB were not statistically
significant.
Of the 22 hypercalcaemic TB patients only two (9%) had
symptoms associated with high calcium concentration. The
first was a 48-year-old man with pulmonary TB who had
polyurea, polydypsia and constipation. The albumin-
adjusted serum calcium concentration and the ionized
calcium concentration were 2?74mmol l71 and
1?37mmol l71, respectively. As soon as he received fluid
hydration, the serum calcium levels came down and the
previous symptoms disappeared. The second patient was a
52-year-old woman with disseminated disease, but without
TABLE 2. Types of TB, albumin–adjusted serum calcium
and ionized calcium levels











All types 2?49+0?21{ 1?27+0?02{
Controls 2?36+0?11{ 1?19+0?02{
*Newman–Keuls multiple comparison test: P>0?05, not
significant difference.
{t-test: P50?01, significant difference.
HYPERCALCAEMIA IN NEWLY-DIAGNOSED TUBERCULOSIS 189clinical or laboratory evidence of bone involvement, who
experienced exactly the same symptoms. The albumin-
adjusted serum concentration and the ionized calcium
concentration were 2?78mmol l71 and 1?39mmol l71,
respectively. The patient needed a short course of systemic
corticosteroids to bring down the serum calcium levels but
recovery was complete.
Discussion
Hypercalcaemia is one of the most common metabolic
emergencies, occurring in approximately 0?5% of hospita-
lized patients. Malignancy is the most common cause of
hypercalcaemia, but other diseases, including acute hyper-
parathyroidism, sarcoidosis and tuberculosis may be
heralded by high calcium concentration (10,11).
In this prospective study we found that hypercalcaemia is
a common laboratory abnormality among Greek patients
with newly-diagnosed TB, before the initiation of anti-
tuberculosis chemotherapy. The presence of hypercalcae-
mia in 25% of our patients is higher than that found in
Hong Kong (15%) and in India (16%) (4,12). It is
comparable to the incidence rate of 27?5% in Malaysia,
but significantly lower than that reported is Australia
(51%) (6,7). This is the first study of calcium concentration
among Greek TB patients before the commencement of
treatment. A previous study during the treatment period
showed high rates of hypercalcaemia (48%) (8).
We have also reported that symptoms associated with
hypercalcaemia are rare among hypercalcaemic TB pa-
tients. The results of our study are consistent with the
conclusion of others who have examined the prevalence of
symptomatic hypercalcaemia in patients with newly-diag-
nosed TB. In the largest series (n=318), Chan reported that
only two patients with abnormal serum calcium concentra-
tion had symptoms related to it (13). Although hypercal-
caemia among TB patients is generally mild and
asymptomatic it can be severe, as seen in some of our
patients and reported by others. Numerous case reportshave documented that symptomatic hypercalcaemia can
occur in patients with tuberculosis during the active phase
of the disease (14–18).
Another common observation in patients with active TB
is the low albumin concentration (19,20). Hypoalbumin-
aemia was present in about two-thirds of our patients at the
time of diagnosis. It could have been related to the
malnutrition that accompanies TB and hypoalbuminaemia
may mask hypercalcaemia. It is known that if the serum
albumin is reduced then total serum calcium may be normal
even though ionized hypercalcaemia is present. However, in
our study, the measurement of both albumin-adjusted and
ionized calcium ensures the accurate evaluation of serum
calcium abnormalities.
Although hypercalcaemia has been known to be asso-
ciated with TB since 1972, the exact pathophysiological
mechanism remains unclear (21). Involvement of the bone
is a possible cause of high calcium concentration (22).
Tuberculosis of bone as a cause of hypercalcaemia in one
patients is unlikely because clinical and laboratory evidence
of bone disease were absent.
Parathyroid hormone (PTH), in association with vitamin
D, is the principal regulator of serum calcium concentra-
tion. PTH increases delivery of calcium from the skeleton to
the extracellular fluid. Additionally, it acts on the kidney to
increase tubular reabsorption of calcium and stimulates the
renal 1-a-hydroxylase enzyme which is responsible for the
1-a hydroxylation of 25-hydroxycholecalciferol [25(OH)D3]
to 1,25-dihydroxyccholecalciferol [1,25(OH)2D3]. The ac-
tive form of vitamin D [1,25 (OH)2D3] increases the
fractional absorption of calcium from the gut (24).
Overproduction of 1,25(OH)D3 has been described in
sarcoidosis and other granulomatours diseases (25,26). T-
lymphocytes (possibly CD8+T-lymphocytes), and alveolar
macrophages obtained by brochoalveolar lavage from
patients with pulmonary TB have been shown to produce
1,25(OH)2D3. This compound is produced by T-cells plays
a critical role in the immune response against mycobacteria
as it is an important component of cell-mediated immunity
to TB (27,28). The produced vitamin D has only a local
effect in enhancing macrophages to kill mycobacteria and
does not normally affect calcium metabolism. However, if
large quantities of 1,25(OH)2D3 are produced, the subse-
quent ‘overspill’ into the circulation results in hypercalcae-
mia (29).
A question remains as to why all TB patients do not
present with high calcium concentration. The differences in
calcium intake could be a first explanation. Another reason
lies in the availability of the substrate 25(OH)D3, which is
synthesized from 7-dehydrocholesterol in the skin. Ultra-
violet light is essential for this reaction. In tropical climates,
where the amount of sun exposure is high, the concentra-
tion of 25(OH)D3 is increased (30). In TB patients,
circulating 25(OH)D3 is used from both kidney and
macrophages for the production of the active vitamin D.
The result is high incidence of hypercalcaemia among TB
patients in countries with abundant sunshine throughout
the year, such as Malaysia and Australia (6,7). The relative
low amount of sun exposure seems to be the cause of low
incidence of hypercalcaemia in TB patients in the U.K. In
190 A. ROUSSOS ET AL.Greece, sunlight is plentiful and this may explain the high
percentage of hypercalcaemia in our study population.
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